Trade Report: Today: Oregon Public Employees Retirement Fund cuts its investment of stake in Colgate-Palmolive Co. (CL)

Today: Oregon Public Employees Retirement Fund cuts its investment of stake in Colgate-Palmolive Co. (CL)

Oregon Public Employees Retirement Fund lowered its stake in Colgate-Palmolive Co. (NYSE:CL) by 37.1% during the third quarter, Holdings Channel reports. The firm owned 91,392 shares of the company’s stock after selling 53,928 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Colgate-Palmolive were worth $6,776,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Emerald Acquisition Ltd. bought a new position in shares of Colgate-Palmolive during the second quarter valued at about $214,435,000. Ameriprise Financial Inc. boosted its position in shares of Colgate-Palmolive by 142.6% in the second quarter. Ameriprise Financial Inc. now owns 1,881,639 shares of the company’s stock valued at $137,710,000 after buying an additional 1,106,185 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Colgate-Palmolive by 1.8% in the second quarter. Vanguard Group Inc. now owns 60,839,484 shares of the company’s stock valued at $4,453,451,000 after buying an additional 1,103,235 shares during the last quarter. Canada Pension Plan Investment Board boosted its position in shares of Colgate-Palmolive by 358.8% in the second quarter. Canada Pension Plan Investment Board now owns 1,231,886 shares of the company’s stock valued at $90,174,000 after buying an additional 963,376 shares during the last quarter. Finally, Bank of Montreal Can bought a new position in shares of Colgate-Palmolive during the second quarter valued at about $64,888,000. Institutional investors own 71.73% of the company’s stock.

Shares of Colgate-Palmolive Co. (NYSE:CL) traded down 0.15% during midday trading on Monday, reaching $66.43. 3,059,571 shares of the company were exchanged. The firm’s 50 day moving average is $69.86 and its 200-day moving average is $72.23. The company has a market capitalization of $59.05 billion, a PE ratio of 43.45 and a beta of 0.73. Colgate-Palmolive Co. has a 52-week low of $61.40 and a 52-week high of $75.38.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Thursday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. The firm earned $3.87 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 8.96% and a return on equity of 6,924.14%. The firm’s revenue was down 3.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.80 earnings per share. On average, equities analysts forecast that Colgate-Palmolive Co. will post $2.82 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 15th. Stockholders of record on Monday, October 24th were issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 2.34%. The ex-dividend date was Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 101.96%.

Several analysts recently commented on CL shares. B. Riley reiterated a “neutral” rating and issued a $71.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, August 3rd. KeyCorp started coverage on shares of Colgate-Palmolive in a research report on Thursday, September 8th. They issued a “sector weight” rating for the company. Bank of America Corp. upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and upped their price target for the company from $70.86 to $80.00 in a research report on Monday, September 12th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 20th. Finally, Wells Fargo & Co. reiterated a “market perform” rating on shares of Colgate-Palmolive in a research report on Tuesday, November 15th. Twelve analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $76.04.

In other news, insider Patricia Verduin sold 3,834 shares of the business’s stock in a transaction on Thursday, September 15th. The shares were sold at an average price of $71.85, for a total transaction of $275,472.90. Following the completion of the transaction, the insider now owns 55,013 shares of the company’s stock, valued at $3,952,684.05. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 1.05% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

Related posts

Leave a Comment